|
First, I want to thank all the great posters here (as well as yahoo)...I have learned so much from bob, manny, etc. here. I haven't finished reading all the messages, so this may already have been posted, but here is my response to the question 'where could this be in '98?' Here goes: the answer depends on whether imnr goes for fasttrack fda approval in november '98 (then fda approval in may '99), or if imnr waits until mar. '99 to go for fastrack (then the approval is around sept/oct. '99). In any event, if fasttrack is opted for this year, then I think you'll see the stock at 30-40 at year end, and 60 upon fda approval in mar 99 (remember other good things will be happening with RA, Gene therapy, etc.) If fast track is not opted for, I think you're looking at 30 dollars year end, and 60 late '99. The next big move will be early-mid july when the stock should go to low to mid twenties upon the valentine data presented as part of the late breaking news at the geneva aids conference. if you're new to the stock, we're at the tip of the iceberg, so don't sell before mid july....let the aids conference presentations take effect. By the way, bob, are you going to call deb altman now and ask her about the promised gene therapy p-ship (ha-ha)? Also, Bob, I met you through this board, and it's been a lot of fun taking this agonizing ride with you...We do have to do some due diligence to find the next one, though...But I'm going to savor this one for a month before I go to work. Besides, I'm holding this for a few more years (we have more than 1 drug in our pipeline which will be approved by the fda)...I'm not going to force anything...if it ain't there, it ain't there...what's up with apco these days??? And if the market doesn't appreciate this news, I'm going to be one pissed off investor! |
